4 - Parathyroid Hormone and Ca Homeostasis Flashcards
(26 cards)
Plasma calcium is regulated by? (3)
PTH
Vitamin D
Calcitonin
PTH secretion is regulated by (1)
Plasma Ca levels
PTH Actions: Bone (2)
Increases bone resorption by increasing the no. and activity of osteoclasts
Induce Receptor Activator Nuclear Factor Kappa-B Ligand (RANKL) –> increases both the numbers and the activity of osteoclasts
PTH Actions: Kidney (2)
Increases the reabsorption of Ca and reduces that of phosphate
Stimualtes the production of 1,25-dihydoxyvitamin D
PTH Actions: Intestines (1)
Indirectly increases absorption of Ca
Teriparatide (Forteo): Defined and Use
Recombinant PTH
Used in osteoporosis in intermittent administration
Calcitonin: Secreted and Regulated (2)
Secreted by parafollicular ‘C’ cells of thyroid
Regulated by plasma Ca levels
Calcitonin Actions: Bone and Kidney
Bone: Inhibits osteoclastic bone resorption
Kidney: Inhibits reabsorption of Ca and PO4
Calcitonin Use (3)
Paget’s Disease
Hypercalcemia
Osteoporosis
Vitamin D3 is also called
Cholecalciferol
Vitamin D2 is also called
Ergocalcierfol
Vitamin D: Activation
Hydroxylated in the liver to 25-hydroxyvitamin D → 1,25-dihydroxyvitamin D (calcitriol)
Vitamin D Actions: Intestine
Increases absorption of Ca and PO4
Vitamin D Actions: Bone
Increases Ca and PO4 resorption
Vitamin D Actions: Kidney
Excretion of Ca ad PO4 is decreased
Vitamin D Uses (4)
Prophylaxis and treatment of Vitamin D deficiency
Rickets: Vit D resistant rickets and Vit D dependant rickets
Renal rickets
Hypoparathyroidism
Biphosphonates: Drugs (4)
Etidronate
Pamidronate
Alendronate
Risendronate
Biphosphonates: Mechanism (3)
Slow formation and dissolution oh hydroxyapatite crystals
Localize to regions of resorption
Block farnesyl pyrophosphate
Biphosphonates: Uses (4)
Osteoporosis
Paget’s Disease
Hypercalcemia of malignancy
Osteoclastic Bone Metastatis
Biphosphonates: Adverse Effects (4)
Decreased renal function
Esophageal motility disorders
Peptic ulcer disease
Osteonecrosis of the jaw (tx with Zolendronate)
What drug inhibits RANKL and it’s use (2) ?
Denusomab (Prolia)
Osteoporosis and giant cell tumor of bone
Cinacalcet: MOA (2)
Activates Calcium-sensing receptor parathyroid gland - calcimimetic
Blocks PTH secretion
Cinacalcet: Use (2)
Secondary hyperparathyroidism in chronic kidney disease
Parathyroid carcinoma
Plicamycin: MOA (1)
Cytotoxic antibiotic that inhibits bone resorption